HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Freeman, E. E. Articles by Grosskreutz, C. L. Search for Related Content PubMed PubMed Citation Articles by Freeman, E. E. Articles by Grosskreutz, C. L.

The Effects of FK506 on Retinal Ganglion Cells after Optic Nerve Crush

From the Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.

PURPOSE. The purpose of this study was twofold: to determine whether immunophilins were present in the rat retina and to determine the physiologic consequence of their presence.

METHODS. Reverse transcription–polymerase chain reaction (RT-PCR) and Western blot analysis were performed on rat retinal tissue, and the immunophilin FKBP12 was found to be present in retina. Immunohistochemical studies showed the presence of FKBP12 in retinal ganglion cells (RGCs). In rats, optic nerve crush was performed on one side and a sham operation on the other side. By gavage, animals were given 5 mg/kg per day of the FKBP12 ligand FK506 in sterile phosphate-buffered saline (PBS) or in PBS alone. Eight days after nerve crush, the total number of back-labeled RGCs was estimated from retinal wholemounts.

RESULTS. In control eyes, the number of labeled ganglion cells was 74,104 ± 4,166 (mean ± SEM) in rats receiving vehicle and 74,993 ± 3,098 in animals receiving FK506 daily. Eight days after optic nerve crush, 27,775 ± 3,332 labeled ganglion cells were counted in retinas of animals receiving vehicle (n = 11), whereas 33% more ganglion cells (37,118 ± 2,475) were counted in animals receiving FK506 daily (n = 11). This difference was statistically significant (P < 0.05).

CONCLUSIONS. The data presented demonstrate that the immunophilin FKBP12 is present in retina and specifically in RGCs. In addition, the FKBP12 ligand FK506 confers neuroprotection on RGCs after optic nerve crush. This neuroprotection may occur as a result of FK506’s ability to interfere with apoptotic mechanisms after optic nerve crush.

This article has been cited by other articles:

				K. Oh-i, H. Keino, H. Goto, N. Yamakawa, M. Takeuchi, M. Usui, and T. Iwasaki Upregulation of neurotrophic factor-related gene expression in retina with experimental autoimmune uveoretinitis by intravitreal injection of tacrolimus (FK506) Br. J. Ophthalmol., November 1, 2007; 91(11): 1537 - 1540. [Abstract] [Full Text] [PDF]

				W. Huang, J. B. Fileta, A. Dobberfuhl, T. Filippopolous, Y. Guo, G. Kwon, and C. L. Grosskreutz Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma PNAS, August 23, 2005; 102(34): 12242 - 12247. [Abstract] [Full Text] [PDF]

				K. Maeda, A. Sawada, M. Matsubara, Y. Nakai, A. Hara, and T. Yamamoto A Novel Neuroprotectant against Retinal Ganglion Cell Damage in a Glaucoma Model and an Optic Nerve Crush Model in the Rat Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 851 - 856. [Abstract] [Full Text] [PDF]